Instrument Inactif

Communiqués Zomedica Corp. Toronto S.E.

Actions

ZOM

CA98980M1095

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform	28/06	AQ
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark	26/06	AQ
Zomedica Announces Presentation of Compelling TRUFORMA Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference	07/06	AQ
Zomedica Enhances TRUFORMA Platform with Launch of Advanced Canine Cortisol Assay	30/05	AQ
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA Platform	16/05	AQ
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform	03/05	AQ
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET	01/05	AQ
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	10/04	AQ
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	15/03	AQ
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	13/03	AQ
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	08/03	AQ
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	06/03	AQ
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences	09/02	AQ
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET	07/02	AQ
Open Letter to Zomedica Shareholders from your Chief Executive Officer	01/02	AQ
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference	31/01	AQ
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position	11/01	AQ
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel 'X-Trode' Handpiece	05/01	AQ
Zomedica to Present at Noble Capital Markets 19th Annual Emerging Growth Equity Conference	29/11	AQ
Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference	21/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Zomedica Corp. Toronto S.E.

Actions

ZOM

CA98980M1095

Communiqués

Filtres